Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03874390
Other study ID # 60078
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2014
Est. completion date February 2016

Study information

Verified date March 2019
Source Ataturk University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to evaluate of ozone therapy on both clinical and biochemical effects in periodontally patients.


Description:

This study is evaluated clinical and biochemical effect of ozone therapy at 8 weeks in periodontitis patients.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date February 2016
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender All
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria:

- systemically healthy

- non-smokers

- chronic periodontitis participants

Exclusion Criteria:

- smokers

- pregnancy or lactation

- individiuals with any systemic disease

Study Design


Related Conditions & MeSH terms


Intervention

Other:
ozone
gaseous ozone was applied on periodontal pocket two times in one week.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical atachment level baseline Calculation as distance in millimeters from cement-enamel junction to the bottom of the pocket by Williams periodontal probe baseline (before treatment)
Primary Plaque index baseline As described by Silness&Löe 1964; The measurement of the state of oral hygiene by Silness-Löe plaque index is based on recording both soft debris and mineralized deposits on the following teeth. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.
Scores 0: No plaque. scores 1: A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.
scores 2: Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.
scores 3: Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.
score 0 considered good oral hygiene, score 3 bad oral hygiene habits. plaque index for a tooth=scores from 4 areas/4 plaque index individiual= scores from 28 tooth/28
baseline (before treatment)
Primary Gingival index baseline As described by Löe&Silness 1963; The bleeding is assessed by probing gently along the wall of soft tissue of the gingival sulcus. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.
score 0 — Normal, healthy gingival with sharp, non-inflamed margins. score 1 — Marginal gingivitis with minimal inflammation and edema at the free gingival. No bleeding on probing.
score 2 — Moderate gingivitis with a wider band of inflammation and bleeding upon probing.
score 3 — Advanced gingivitis with inflammation clinically reaching the mucogingival junction usually with ulceration.
score 0 considered healty gingiva, score 3 assesed advanced gingival disease. gingival index for a tooth=scores from 4 areas/4 gingival index individiual= scores from 28 tooth/28
baseline (before treatment)
Primary Bleeding on probing baseline As described by Ainamo&Bay 1975; The index is performed through gentle probing of the orifice of the gingival crevice. If bleeding occurs within 10 seconds a positive finding is recorded and the number of positive sites is recorded and then expressed as a percentage of the number of sites examined.
bleeding present (+) absent (-) bleeding surface/all surface *100=% bleeding absent recording is equivalent to gingival index scores 0&1. bleeding present recording is equivalent to gingival index score 2&3.
0: no bleeding on probing, healty gingiva
100: all gingiva bleeding on probing; diseased gingiva.
baseline (before treatment)
Primary Probing of depth baseline Measurement to the nearest millimeter from the gingival margin to the base of the clinical pocket by Williams periodontal probe baseline (before treatment)
Primary Biochemical outcomes baseline In this study, biochemical parametres including IL-1B, IL-6, IL-10, TNF-a, MMP-9 were measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) methods on Gingival Crevicular Fluid at baseline. baseline (before treatment)
Secondary Clinical attachment level after 8 weeks Calculation as distance in millimeters from cement-enamel junction to the bottom of the pocket by Williams periodontal probe 8 weeks after treatment
Secondary Plaque index after 8 weeks As described by Silness&Löe 1964; The measurement of the state of oral hygiene by Silness-Löe plaque index is based on recording both soft debris and mineralized deposits on the following teeth. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.
Scores 0: No plaque scores 1: A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface.
scores 2: Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye.
scores 3: Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.
score 0 considered good oral hygiene, score 3 bad oral hygiene habits. plaque index for a tooth=scores from 4 areas/4 plaque index individiual= scores from 28 tooth/28
8 weeks after treatment
Secondary Gingival index after 8 weeks As described by Löe&Silness 1963; The bleeding is assessed by probing gently along the wall of soft tissue of the gingival sulcus. Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3.
score 0 — Normal, healthy gingival with sharp, non-inflamed margins. score 1 — Marginal gingivitis with minimal inflammation and edema at the free gingival. No bleeding on probing.
score 2 — Moderate gingivitis with a wider band of inflammation and bleeding upon probing.
score 3 — Advanced gingivitis with inflammation clinically reaching the mucogingival junction usually with ulceration. score 0 considered healty gingiva, score 3 assesed advanced gingival disease.
gingival index for a tooth=scores from 4 areas/4 gingival index individiual= scores from 28 tooth/28
8 weeks after tretament
Secondary Bleeding on probing after 8 weeks As described by Ainamo&Bay 1975; the index is performed through gentle probing of the orifice of the gingival crevice. If bleeding occurs within 10 seconds a positive finding is recorded and the number of positive sites is recorded and then expressed as a percentage of the number of sites examined.
bleeding present (+) absent (-) bleeding surface/all surface *100=% bleeding absent recording is equivalent to gingival index scores 0&1. bleeding present recording is equivalent to gingival index score 2&3.
0: no bleeding on probing, healty gingiva
100: all gingiva bleeding on probing; diseased gingiva.
8 weeks after treatment
Secondary Probing of dept after 8 weeks Measurement to the nearest millimeter from the gingival margin to the base of the clinical pocket by Williams periodontal probe 8 weeks after tretament
Secondary Biochemical outcomes after 8 weeks In this study, biochemical parametres including IL-1B, IL-6, IL-10, TNF-a, MMP-9 were measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) measured (pg/ml) by ELISA (Enzyme-Linked Immuno Sorbent Assay) methods on Gingival Crevicular Fluid at 8 weeks 8 weeks after tretment
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06400069 - Role of NLRP6 in Chronic Periodontitis
Completed NCT05231096 - Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis N/A
Completed NCT03203746 - Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis Phase 1/Phase 2
Active, not recruiting NCT03354338 - Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy Phase 2
Completed NCT02516111 - Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment Phase 2/Phase 3
Completed NCT02174146 - Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy N/A
Terminated NCT02568163 - Influence of Stress on Non Surgical Periodontal Treatment N/A
Completed NCT02430519 - Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects N/A
Completed NCT01438333 - Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection N/A
Completed NCT01233765 - Analysis of Neutrophil Response in Chronic Periodontitis N/A
Completed NCT02218515 - Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft Phase 4
Completed NCT02197260 - Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing Phase 4
Not yet recruiting NCT03270280 - Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis Phase 2
Not yet recruiting NCT04026828 - Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
Completed NCT04697199 - The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis Phase 1
Completed NCT04643288 - Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects N/A
Completed NCT03039244 - Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers N/A
Completed NCT02898675 - Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing N/A
Completed NCT02851823 - Combined Use of Er:YAG and Nd:YAG Laser N/A
Completed NCT02518152 - Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis Phase 2/Phase 3